Joanne M. Hackett
Equibles does not estimate personal net worth.
Get an email with a short summary when Serina Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SER alertsAbout Joanne M. Hackett
Joanne M. Hackett is recorded as CEO at Serina Therapeutics, Inc. (SER). The newest filing on record that lists Joanne M. Hackett as CEO at Serina Therapeutics, Inc. (SER) is dated November 7, 2023. Serina Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Joanne M. Hackett resigned as board of directors, effective March 26, 2024. Serina Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Joanne M. Hackett was terminated as interim CEO, effective March 26, 2024. The proxy statement of Serina Therapeutics, Inc. reports total compensation of $51,183 for Joanne M. Hackett in fiscal 2024, including a base salary of $51,183. Disclosed compensation is on record for 3 fiscal years. Serina Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Serina Therapeutics, Inc. includes Steve Ledger (CEO), Steven Ledger (CEO and Board Member), Gregory H. Bailey (Chairman and Board Member) and 7 others.
“both Dr. Joanne M. Hackett and Dr. Jean-Christophe Renondin resigned from AgeX's board of directors and all respective committee membership of AgeX's board of directors, effective as of the effective time of the Merger”
“Dr. Hackett was terminated as interim CEO of the Company effective as of the effective time of the Merger.”
Affiliation history
-
Current
Start not stated–present
Last confirmed November 7, 2023
-
2023-01-01–2024-03-26
Company network
Leadership on record at Serina Therapeutics, Inc.
- Steve Ledger CEO
- Steven Ledger CEO, Board Member
- Gregory H. Bailey Chairman, Board Member
- J. Milton Harris Chairman, Board Member
- Lead Investor Chairman
- Simba Gill Chairman
- Simba Gill, Ph.D. Chairman
- Andrea E. Park CFO, Chief Accounting Officer
- Andrea Park CFO, Chief Accounting Officer
- Gregory S. Curhan CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Serina Therapeutics, Inc. (SER) | Former Interim Chief Executive Officer | $51,183 | $51,183 |
| 2023 | Serina Therapeutics, Inc. (SER) | Former Interim Chief Executive Officer | $63,227 | $102,850 |
| 2022 | Serina Therapeutics, Inc. (SER) | Interim Chief Executive Officer | — | $103,065 |